Source: Benzinga

Tempus: Tempus AI Stock Is Ripping Higher Wednesday: What's Fueling The Move?

Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI. read more

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
Eric Lefkofsky's photo - Founder & CEO of Tempus

Founder & CEO

Eric Lefkofsky

CEO Approval Rating

100/100

Read more